Aptivus and Lamivudine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Aptivus (tipranavir) and Lamivudine (lamivudine; zidovudine; nevirapine). Common drug interactions include dysphagia among females and haemorrhage intracranial among males.

The phase IV clinical study analyzes what interactions people have when they take Aptivus and Lamivudine. It is created by eHealthMe based on reports of 25 people who take the same drugs from the FDA, and is updated regularly.

What is Aptivus?

Aptivus has active ingredients of tipranavir. eHealthMe is studying from 1,060 Aptivus users. Check the latest studies of Aptivus.

What is Lamivudine?

Lamivudine has active ingredients of lamivudine; zidovudine; nevirapine. It is often used in hiv infection. eHealthMe is studying from 17,242 Lamivudine users. Check the latest studies of Lamivudine.

On Jul, 19, 2026

25 people who take Aptivus and Lamivudine together, and have interactions are studied.

Aptivus and Lamivudine drug interactions.

What are the common drug interactions of Aptivus and Lamivudine, by gender? *:

female:

Dysphagia (a condition in which swallowing is difficult or painful)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
Drug resistance (reduction in effectiveness of a drug)
Immune reconstitution syndrome (immune recovery syndrome)
Skin toxicity (skin damage due to toxin/poison)

male:

Haemorrhage intracranial (bleeding within the skull)
Cerebral haematoma (collection of blood in brain)
Bradycardia (abnormally slow heart action)
Brain abscess
Confusional state
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Cystic lymphangioma (uncommon tumours that can arise from any part of the body)
Epistaxis (bleed from the nose)
Fall
Head injury

What are the common drug interactions of Aptivus and Lamivudine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Drug resistance (reduction in effectiveness of a drug)

10-19:

Dysphagia (a condition in which swallowing is difficult or painful)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)

20-29:

n/a

30-39:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Cytomegalovirus chorioretinitis (infection of choroid and retina of the eye from virus)
Hepatitis (inflammation of the liver)
Immune reconstitution syndrome (immune recovery syndrome)
Skin toxicity (skin damage due to toxin/poison)

40-49:

Kaposi's sarcoma (a tumour caused by human herpes virus)
Kaposi's sarcoma aids related (a tumour caused by human herpes virus associated with aids)
Splenic haemorrhage (bleeding from spleen)
Syncope (loss of consciousness with an inability to maintain postural tone)
Blood hiv rna increased
Splenic rupture

50-59:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Haemorrhage intracranial (bleeding within the skull)
Hypertension (high blood pressure)
Lung neoplasm malignant (cancer tumour of lung)

60+:

Cerebral haematoma (collection of blood in brain)
Cerebral haemorrhage (bleeding within the brain)
Gastritis haemorrhagic (inflammation of stomach with bleeding)
Upper gastrointestinal haemorrhage (upper gastrointestinal bleeding)

What are the existing conditions these people have? *

Hiv Test Positive: 6 people, 24.00%
Acquired Immunodeficiency Syndrome (disease of the human immune system caused by the human immunodeficiency virus (hiv)): 4 people, 16.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 2 people, 8.00%

* Approximation only. Some reports may have incomplete information.

Do you take Aptivus and Lamivudine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously